Transaction Details

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 5, 2025. | The price range for the aggregate amount sold by the direct holder is $173.43 - $174.42. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. | The price range for the aggregate amount sold by the direct holder is $174.44 - $175.34. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. | The price range for the aggregate amount sold by the direct holder is $175.49 - $175.88. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. | The common stock number referred in Table I is an aggregate number and represents 16,695 shares of common stock and 1,474 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 16, 2026.